Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

156,481-156,540 of 319,975

filter-aware
01
Slide 1
23andMe | Internal Communication Presentation Deck | 13 slides23andMe | Internal Communication Presentation Deck | 13 slides · 23andMe
Other Investor relations 1 hit
02
23andMe | Internal Communication Presentation Deck | 13 slides23andMe | Internal Communication Presentation Deck | 13 slides · 23andMe
Other Investor relations 1 hit
03
23andMe | Internal Communication Presentation Deck | 13 slides23andMe | Internal Communication Presentation Deck | 13 slides · 23andMe
Other Investor relations 1 hit
04
23andMe | Internal Communication Presentation Deck | 13 slides23andMe | Internal Communication Presentation Deck | 13 slides · 23andMe
Other Investor relations Beat · Situation & Context1 hit
05
23andMe | Internal Communication Presentation Deck | 13 slides23andMe | Internal Communication Presentation Deck | 13 slides · 23andMe
Other Investor relations 1 hit
06
23andMe | Internal Communication Presentation Deck | 13 slides23andMe | Internal Communication Presentation Deck | 13 slides · 23andMe
Other Investor relations Beat · Evidence & Proof1 hit
07
The slide provides specific financial mechanics for option holders regarding the merger exchange ratio.23andMe | Internal Communication Presentation Deck | 13 slides · 23andMe
Other Investor relations Beat · Evidence & Proof1 hit
08
The slide demonstrates how a conversion factor affects the number of options and the strike price while keeping the total option strike price constant.23andMe | Internal Communication Presentation Deck | 13 slides · 23andMe
Other Investor relations Beat · Evidence & Proof1 hit
09
23andMe | Internal Communication Presentation Deck | 13 slides23andMe | Internal Communication Presentation Deck | 13 slides · 23andMe
Other Investor relations Beat · Evidence & Proof1 hit
10
23andMe | Internal Communication Presentation Deck | 13 slides23andMe | Internal Communication Presentation Deck | 13 slides · 23andMe
Other Investor relations 1 hit
11
23andMe | Internal Communication Presentation Deck | 13 slides23andMe | Internal Communication Presentation Deck | 13 slides · 23andMe
Other Investor relations Loop · Voice Of Customer1 hit
12
23andMe | Internal Communication Presentation Deck | 13 slides23andMe | Internal Communication Presentation Deck | 13 slides · 23andMe
Other Investor relations Loop · Voice Of Customer1 hit
13
23andMe | Internal Communication Presentation Deck | 13 slides23andMe | Internal Communication Presentation Deck | 13 slides · 23andMe
Other Investor relations Beat · Impact & Next Steps1 hit
01
Slide 1
The background consists of a repeating pattern of A, C, G, T nucleotides.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Humble Origins1 hit
02
23andMe | SPAC Presentation Deck | 47 slides23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Humble Origins1 hit
03
The slide features headshots of four executives with their titles and associated company logos.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Humble Origins1 hit
04
23andMe | SPAC Presentation Deck | 47 slides23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Humble Origins1 hit
05
The background contains a repeating pattern of A, C, G, T letters, referencing DNA sequencing.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Humble Origins1 hit
06
The chart highlights 23andMe's 10.7M participants compared to other well-known biobanks and research programs.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Early StrugglesLoop · Logic Chain1 hit
07
Uses a split-screen layout with a strong emotional quote on the left and quantitative evidence on the right.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Early StrugglesLoop · Logic Chain1 hit
08
Uses a list of industry-disruptor pairs to establish a pattern of consumer-led change.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Early StrugglesLoop · Logic Chain1 hit
09
The slide uses a timeline to demonstrate regulatory milestones and credibility.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Early StrugglesLoop · Logic Chain1 hit
10
The slide combines quantitative traction metrics with a qualitative customer story.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Early StrugglesLoop · Logic Chain1 hit
11
The slide highlights the cross-disciplinary background of the team (Tech, Biotech, Healthcare) and lists notable past affiliations and investors.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Rising SuccessLoop · Logic Chain1 hit
12
The background features a repeating pattern of A, C, G, T letters, representing DNA nucleotides.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Rising SuccessLoop · Logic Chain1 hit
13
The background features a repeating pattern of A, C, G, T letters, referencing DNA base pairs.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Rising SuccessLoop · Logic Chain1 hit
14
The chart highlights the achievement of 10M+ genetic profiles as a critical mass point.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Rising SuccessLoop · Logic Chain1 hit
15
The slide uses a circular flow diagram to illustrate the network effect between consumer data and therapeutic/product output.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Rising SuccessLoop · Logic Chain1 hit
16
The slide highlights the user-facing product features that drive data collection for the company's database.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Rising SuccessLoop · Logic Chain1 hit
17
Uses a flow diagram to show the gap in the current healthcare system for BRCA testing.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Rising SuccessLoop · Logic Chain1 hit
18
Includes a footnote regarding FDA authorization for wellness reports.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Rising SuccessLoop · Logic Chain1 hit
19
The slide uses a grid of metrics to demonstrate the scale of the user base and their willingness to contribute data.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Rising SuccessLoop · Logic Chain1 hit
20
23andMe | SPAC Presentation Deck | 47 slides23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Rising SuccessLoop · Logic Chain1 hit
21
The slide highlights the value proposition of the subscription service with a visual mockup of the mobile app interface.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · The Breakthrough1 hit
22
The chart displays a combination of a bar chart for daily subscribers and a line chart for cumulative active subscribers.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · The Breakthrough1 hit
23
Uses a visual contrast framework to illustrate the shift from one-size-fits-all to individualized care.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · The Breakthrough1 hit
24
The slide uses a visual flow from the product (saliva kit) to a list of integrated healthcare services.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · The Breakthrough1 hit
25
The slide uses a DNA-themed background (A, C, G, T letters) and a numbered circle '3' to indicate a section transition.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · The Breakthrough1 hit
26
The slide uses a split-screen layout with a blue background on the left for the core problem statement and a white background on the right for supporting metrics.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · The BreakthroughLoop · Cost Of Inaction1 hit
27
Uses a comparison frame to highlight competitive advantage in drug development metrics.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · The BreakthroughLoop · Cost Of Inaction1 hit
28
The slide uses a combination of a grid of metrics for health conditions and a vertical timeline for the COVID-19 study.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · The BreakthroughLoop · Cost Of Inaction1 hit
29
Uses a line chart for growth and Manhattan plots for qualitative improvement over time.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · The BreakthroughLoop · Cost Of Inaction1 hit
30
Uses a funnel metaphor to represent the narrowing of research focus from broad data to specific drug targets.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · The BreakthroughLoop · Cost Of Inaction1 hit
31
Includes a testimonial from Dr. Hal Barron of GSK.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
32
The slide uses a horizontal bar chart format to represent drug development stages.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
33
The slide uses a three-step process flow (Market -> Validation -> Mechanism) to justify the CD96 program.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
34
The slide uses a three-step process flow: discovery/mechanism, validation, and development timeline.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
35
The chart shows a clear upward trend in validated targets over time.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
36
The background features a repeating pattern of DNA base pairs (A, C, G, T), suggesting a biotech or life sciences company.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
37
The chart displays cumulative genotyped customers in millions from FY15A to FY21E.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Ultimate Achievement1 hit
38
The slide uses a waterfall-style progression for EBITDA and a table for key financial metrics across fiscal years 2019-2024.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Ultimate Achievement1 hit
39
The slide uses bar charts to project growth across two distinct business segments.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Ultimate Achievement1 hit
40
Includes both historical (A) and estimated (E) data points.23andMe | SPAC Presentation Deck | 47 slides · 23andMe
Pitch deck Investment bank Beat · Ultimate Achievement1 hit
23
The chart illustrates a shift in revenue composition, with existing buyers accounting for a larger share (69%) of total revenue by Q3 2020 compared to 57% in Q1 2017.Wish | SPAC Presentation Deck | 29 slides · Wish
Pitch deck Investment bank Beat · Traction1 hit
24
The slide uses a combination of grouped bar charts and line charts to visualize cohort performance. The note at the bottom clarifies the LTV calculation method.Wish | SPAC Presentation Deck | 29 slides · Wish
Pitch deck Investment bank Beat · Traction1 hit
25
The slide highlights capital efficiency by contrasting cash flow/EBITDA with low Capex requirements.Wish | SPAC Presentation Deck | 29 slides · Wish
Pitch deck Investment bank Beat · Traction1 hit
26
Wish | SPAC Presentation Deck | 29 slidesWish | SPAC Presentation Deck | 29 slides · Wish
Pitch deck Investment bank Beat · Business Model1 hit
27
Wish | SPAC Presentation Deck | 29 slidesWish | SPAC Presentation Deck | 29 slides · Wish
Pitch deck Investment bank 1 hit
28
Standard financial disclosure slide for non-GAAP metrics.Wish | SPAC Presentation Deck | 29 slides · Wish
Pitch deck Investment bank 1 hit
29
Wish | SPAC Presentation Deck | 29 slidesWish | SPAC Presentation Deck | 29 slides · Wish
Pitch deck Investment bank 1 hit